{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:56:26Z","timestamp":1794704186612,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research","award":["na"],"award-info":[{"award-number":["na"]}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1136\/ijgc-2020-001362","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T06:15:22Z","timestamp":1588745722000},"page":"1331-1339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia"],"prefix":"10.1016","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct01686126","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01686126","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S","family":"Mandelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Khoshchehreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Pursuwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise B","family":"Morocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina E","family":"Dancz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begum","family":"Ozel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001362_bb0010","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","article-title":"Management of endometrial precancers","volume":"120","author":"Trimble","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001362_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001362_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2015.07.108","article-title":"Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia","volume":"139","author":"Matsuo","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.033","article-title":"Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy","volume":"132","author":"Gunderson","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001362_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2012.01.009","article-title":"Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway","volume":"125","author":"Hanna","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2009.09.024","article-title":"Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy","volume":"116","author":"Cantrell","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/annonc\/mdv539","article-title":"Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer","volume":"27","author":"Mitsuhashi","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3802\/jgo.2014.25.3.214","article-title":"Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia","volume":"25","author":"Shan","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0060","article-title":"Metformin for endometrial hyperplasia","volume":"10","author":"Clement","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2020-001362_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001362_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.12.273","article-title":"Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy","author":"Mandelbaum","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001362_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00404-019-05059-2","article-title":"Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia","volume":"299","author":"Ciccone","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2020-001362_bb0080","unstructured":"CDC . Defining Adult Overweight and Obesity, Overweight & Obesity. Available: https:\/\/www.cdc.gov\/obesity\/adult\/defining.html [Accessed 13 Jan 2020]."},{"key":"10.1136\/ijgc-2020-001362_bb0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1136\/ijgc-2020-001362_bb0090","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40262-015-0270-6","article-title":"A comprehensive review of drug-drug interactions with metformin","volume":"54","author":"Stage","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1136\/ijgc-2020-001362_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.pgp.0000225845.67245.b3","article-title":"Expression of organic cation transporter SLC22A16 in human endometria","volume":"26","author":"Sato","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1136\/ijgc-2020-001362_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2015.12.010","article-title":"Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer","volume":"140","author":"Cholakian","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0105","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0110","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1158\/1078-0432.CCR-18-3339","article-title":"Pre-surgical metformin in uterine malignancy (PREMIUM): a multi-center, randomized double-blind, placebo-controlled phase III trial","volume":"25","author":"Kitson","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2020-001362_bb0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-Inflammatory effects of metformin irrespective of diabetes status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ Res"},{"key":"10.1136\/ijgc-2020-001362_bb0120","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e90","article-title":"Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients","volume":"30","author":"Mitsuhashi","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001362_bb0125","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001362_bb0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/modpathol.3880053","article-title":"Problems in the differential diagnosis of endometrial hyperplasia and carcinoma","volume":"13","author":"Silverberg","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2020-001362_bb0135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/PAS.0b013e318159a2a0","article-title":"Diagnosing endometrial hyperplasia: why is it so difficult to agree?","volume":"32","author":"Allison","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2020-001362_bb0140","unstructured":"Improving the treatment for women with early stage cancer of the uterus (feMMe) . Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01686126 [Accessed 14 Jan 2020]."},{"key":"10.1136\/ijgc-2020-001362_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cct.2014.06.014","article-title":"Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device \u00b1 metformin \u00b1 weight loss in endometrial cancer (feMME) trial","volume":"39","author":"Hawkes","year":"2014","journal-title":"Contemp Clin Trials"}],"updated-by":[{"DOI":"10.1136\/ijgc-2020-001362corr1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2400656X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2400656X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:26:04Z","timestamp":1753233964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2400656X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1048891X2400656X"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001362","relation":{"erratum":[{"id-type":"doi","id":"10.1136\/ijgc-2020-001362corr1","asserted-by":"object"}],"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2020-001362.supp1","asserted-by":"subject"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}